Joshua Bornstein, MD
NPI 1437500360 · Dermatology Physician · Ann Arbor, MI
Enrolled with Medicare as Practitioner - Dermatology · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Provider details
- NPI number
- 1437500360
- Entity type
- Individual
- Primary specialty
- Dermatology PhysicianAllopathic & Osteopathic Physicians
- Credential
- MD
- Sex
- Male
- Sole proprietor
- Yes
- License
- 4301110619 (MI)
Specialties & taxonomies
Allopathic & Osteopathic Physicians
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure25% of score
9 yrs in NPPES registry
- Profile completeness25% of score
100% of core fields populated
- Practice footprint15% of score
3 documented practice locations
- Medicare service volume (vs. specialty peers)25% of score
1,058 Medicare services, 2024 (ranked within specialty)
- Open Payments transparency10% of score
Has Open Payments disclosures (2024)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our .
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Destruction of Precancer Skin Growth, 2-14 Growths17003 | 389 | $6 |
| Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213 | 150 | $90 |
| Destruction of Precancer Skin Growth, 1 Growth17000 | 125 | $54 |
| Biopsy of Related Skin Growth, First Growth11102 | 93 | $89 |
| New Patient Office Or Other Outpatient Visit With Low Level of Medical Decision Making, If Using Time, 30 Minutes Or More99203 | 85 | $110 |
| Destruction of Skin Growth, 1-14 Growths |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 14 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Triamcinolone Acetonide | 103 | 62 |
| Mupirocin | 69 | 60 |
| Ketoconazole | 65 | 44 |
| Betamethasone Dipropionate | 59 | 49 |
| Clobetasol Propionate | 52 | 30 |
| Econazole Nitrate | 26 | 16 |
| Prednisone | 25 | 19 |
| Fluorouracil | 24 |
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$472 across 20 records (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Additional practice locations (2)
- 416 S Creyts Rd Ste aLansing, MI 48917-8290Phone: (517) 886-0333Fax: (517) 886-2072
- 6100 Newport Rd Ste 100Portage, MI 49002-9235Phone: (269) 343-4679Fax: (269) 343-5929
Registry dates
- Enumerated
- 2016-06-22
- Last updated
- 2024-02-28
- Certified
- 2024-02-28
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.